title: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.
abstract: OBJECTIVE
  To evaluate the validity of patient report, pharmacy dispensing records, and pill counts as measures of antihypertensive adherence using electronic monitoring as the validation standard.
  
  
  METHODS
  The study was conducted among 286 members of Harvard Pilgrim Health Care, a managed care organization, who were at least 18 years of age, on monotherapy for hypertension, and had prescription drug coverage. Prescription refill adherence during the 12 months before enrollment was determined from their automated pharmacy dispensing records. Participants were interviewed about their medication adherence before and after a 3-month electronic monitoring period during which pill counts were also performed. Adherence to both recommended number and timing of doses was estimated from electronic monitoring data. Data analysis was based on statistical correlation and analysis of variance.
  
  
  RESULTS
  Electronic adherence monitoring revealed that the proportion of prescribed doses consumed was higher (0.92) than the proportion of doses taken on time (0.63). The correlation between adherence to quantity and timing of doses was 0.32. Concurrent pill counts and earlier refilling patterns were moderately correlated with electronic monitoring (pill count: r = .52 with quantity and r = .17 with timing; refill adherence r = .32 with quantity and r = .22 with timing). There was considerable misclassification of adherence reported by patients, although nonadherence was generally accurately reported.
  
  
  CONCLUSIONS
  Deviation from recommended timing of doses appears to be greater than from prescribed number of doses. Pharmacy dispensing records demonstrate predictive validity as measures of cumulative exposure and gaps in medication supply. Adherence levels determined from pill counts and pharmacy dispensing records correlate more closely with quantity than with timing of doses. Nonadherence reported by patients can serve as a qualitative indicator and predictor of reduced adherence.
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: P W
authors.initials: PW
authors.lastname: Choo
authors.forename: C S
authors.initials: CS
authors.lastname: Rand
authors.forename: T S
authors.initials: TS
authors.lastname: Inui
authors.forename: M L
authors.initials: ML
authors.lastname: Lee
authors.forename: E
authors.initials: E
authors.lastname: Cain
authors.forename: M
authors.initials: M
authors.lastname: Cordeiro-Breault
authors.forename: C
authors.initials: C
authors.lastname: Canning
authors.forename: R
authors.initials: R
authors.lastname: Platt
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001900:Boston; D016303:Clinical Pharmacy Information Systems / Q000458:organization & administration*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D008329:Managed Care Programs; D016347:Medical Records Systems, Computerized; D008875:Middle Aged; D018670:Monitoring, Ambulatory; D010349:Patient Compliance / Q000706:statistics & numerical data*; D015203:Reproducibility of Results; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D000959:Antihypertensive Agents